Page last updated: 2024-09-05

glaucocalyxin b and Cancer of Ovary

glaucocalyxin b has been researched along with Cancer of Ovary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, J; Ni, D; Qiu, C; Wu, F; Xiao, Z; Xu, C; Zhang, J; Zhang, T; Zhang, X; Zheng, P; Zhu, J; Zou, P	1

Other Studies

1 other study(ies) available for glaucocalyxin b and Cancer of Ovary

Article	Year
Glaucocalyxin B Attenuates Ovarian Cancer Cell Growth and Cisplatin Resistance In Vitro via Activating Oxidative Stress. Oxidative medicine and cellular longevity, 2022, Volume: 2022 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Diterpenes, Kaurane; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Isodon; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Ovarian Neoplasms; Oxidative Stress; Phytochemicals; Plant Extracts; Reactive Oxygen Species	2022

Article

Year

Glaucocalyxin B Attenuates Ovarian Cancer Cell Growth and Cisplatin Resistance In Vitro via Activating Oxidative Stress.

Oxidative medicine and cellular longevity, 2022, Volume: 2022

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Diterpenes, Kaurane; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Isodon; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Ovarian Neoplasms; Oxidative Stress; Phytochemicals; Plant Extracts; Reactive Oxygen Species

2022